Sign In

Andrew Allen

President, CEO & Co-Founder at Gritstone Oncology

Andrew Allen is a highly accomplished professional with a diverse background in the medical and pharmaceutical industries. He earned his MA BM BCh from the University of Oxford and later pursued a Doctor of Philosophy (PhD) from Imperial College London. Andrew has held key positions in several renowned organizations, including TCR² Therapeutics Inc., Sierra Oncology, Gritstone Oncology, Epizyme, Cell Design Labs, Clovis Oncology, Pharmion Inc, Chiron Corporation, Abbott Laboratories, and McKinsey & Company.

Andrew Allen
Add to my network

Location

San Francisco, California